hydrochloric acid has been researched along with Myelodysplastic Syndromes in 1 studies
Hydrochloric Acid: A strong corrosive acid that is commonly used as a laboratory reagent. It is formed by dissolving hydrogen chloride in water. GASTRIC ACID is the hydrochloric acid component of GASTRIC JUICE.
hydrogen chloride : A mononuclear parent hydride consisting of covalently bonded hydrogen and chlorine atoms.
Myelodysplastic Syndromes: Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Raza, A | 1 |
| Galili, N | 1 |
| Callander, N | 1 |
| Ochoa, L | 1 |
| Piro, L | 1 |
| Emanuel, P | 1 |
| Williams, S | 1 |
| Burris, H | 1 |
| Faderl, S | 1 |
| Estrov, Z | 1 |
| Curtin, P | 1 |
| Larson, RA | 1 |
| Keck, JG | 1 |
| Jones, M | 1 |
| Meng, L | 1 |
| Brown, GL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase 1-2a Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome[NCT00035867] | Phase 1/Phase 2 | 65 participants | Interventional | 2002-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for hydrochloric acid and Myelodysplastic Syndromes
| Article | Year |
|---|---|
Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Dose-Response Relationship, Drug; Female; Glu | 2009 |